» Articles » PMID: 18374598

Clarification of the Role of N-glycans on the Common Beta-subunit of the Human IL-3, IL-5 and GM-CSF Receptors and the Murine IL-3 Beta-receptor in Ligand-binding and Receptor Activation

Overview
Journal Cytokine
Date 2008 Apr 1
PMID 18374598
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-5 are related cytokines that play key roles in regulating the differentiation, proliferation, survival and activation of myeloid blood cells. The cell surface receptors for these cytokines are composed of cytokine-specific alpha-subunits and a common beta-receptor (betac), a shared subunit that is essential for receptor signaling in response to GM-CSF, IL-3 and IL-5. Previous studies have reached conflicting conclusions as to whether N-glycosylation of the betac-subunit is necessary for functional GM-CSF, IL-3 and IL-5 receptors. We sought to clarify whether betac N-glycosylation plays a role in receptor function, since all structural studies of human betac to date have utilized recombinant protein lacking N-glycosylation at Asn(328). Here, by eliminating individual N-glycans in human betac and the related murine homolog, beta(IL-3), we demonstrate unequivocally that ligand-binding and receptor activation are not critically dependent on individual N-glycosylation sites within the beta-subunit although the data do not preclude the possibility that N-glycans may exert some sort of fine control. These studies support the biological relevance of the X-ray crystal structures of the human betac domain 4 and the complete ectodomain, both of which lack N-glycosylation at Asn(328).

Citing Articles

Genome-wide association study of Mycobacterium avium subspecies Paratuberculosis infection in Chinese Holstein.

Gao Y, Jiang J, Yang S, Cao J, Han B, Wang Y BMC Genomics. 2018; 19(1):972.

PMID: 30591025 PMC: 6307165. DOI: 10.1186/s12864-018-5385-3.


The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.

Varghese L, Defour J, Pecquet C, Constantinescu S Front Endocrinol (Lausanne). 2017; 8:59.

PMID: 28408900 PMC: 5374145. DOI: 10.3389/fendo.2017.00059.


High yield production of a soluble human interleukin-3 variant from E. coli with wild-type bioactivity and improved radiolabeling properties.

Hercus T, Barry E, Dottore M, McClure B, Webb A, Lopez A PLoS One. 2013; 8(8):e74376.

PMID: 23991218 PMC: 3753260. DOI: 10.1371/journal.pone.0074376.


Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels.

Albu R, Constantinescu S Front Endocrinol (Lausanne). 2012; 2:71.

PMID: 22649382 PMC: 3355985. DOI: 10.3389/fendo.2011.00071.


The role of interchain heterodisulfide formation in activation of the human common beta and mouse betaIL-3 receptors.

Mirza S, Chen J, Murphy J, Young I J Biol Chem. 2010; 285(32):24759-68.

PMID: 20516062 PMC: 2915712. DOI: 10.1074/jbc.M109.097881.